-
5061
-
5062
-
5063
-
5064
-
5065
An Optimized NGS Workflow Defines Genetically Based Prognostic Categories for Patients with Uveal Melanoma
Published 2025-01-01Get full text
Article -
5066
Diabetes Mellitus, Extreme Insulin Resistance, and Hypothalamic-Pituitary Langerhans Cells Histiocytosis
Published 2019-01-01Get full text
Article -
5067
-
5068
-
5069
Recomendaciones para el diagnóstico y tratamiento de las vasculitis asociadas a anticuerpos anticitoplasma de neutrófilo
Published 2025-01-01“…In recent years, a better knowledge of B lymphocyte function and the role of complement inhibition has transformed the course of this disease while minimising treatment-related adverse effects.This multidisciplinary document of recommendations is based on the consensus of three scientific societies (Internal Medicine, Nephrology and Rheumatology) and on the best available evidence on diagnosis, treatment and follow-up of patients with ANCA-associated vasculitis, including some special situations. …”
Get full text
Article -
5070
-
5071
-
5072
-
5073
Recommendations for the diagnosis and treatment of anti-neutrophil cytoplasmic autoantibody associated vasculitis
Published 2025-01-01“…In recent years, a better knowledge of B lymphocyte function and the role of complement inhibition has transformed the course of this disease while minimising treatment-related adverse effects.This multidisciplinary document of recommendations is based on the consensus of three scientific societies (Internal Medicine, Nephrology and Rheumatology) and on the best available evidence on diagnosis, treatment and follow-up of patients with ANCA-associated vasculitis, including some special situations. …”
Get full text
Article -
5074
-
5075
-
5076
Addressing the overuse of hospital emergency departments in the Portuguese NHS: a new paradigm
Published 2025-01-01Get full text
Article -
5077
-
5078
Multi-dimensional outcomes following extracorporeal cardiopulmonary resuscitation
Published 2025-03-01Get full text
Article -
5079
-
5080
Effect of Bacille Calmette–Guérin vaccination on immune responses to SARS‐CoV‐2 and COVID‐19 vaccination
Published 2025-01-01Get full text
Article